Methylation of cell cycle regulating genes like p16INK4A has been found to be associated with progression of CML disease and is reported to be associated with late stage CML disease in other studies [33, 34]. The gene discussed is CDKN2A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.